𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levamisole in chronic hepatitis: A favorable trend is not enough

✍ Scribed by Jay H. Hoofnagle

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
272 KB
Volume
7
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

The group at Pittsburgh have a vast experience with liver transplantation. They have shown that the procedure is effective and may be lifesaving. They now show that modem methods of immunosuppression can even allow liver transplantation across traditional ABO barriers. The price is high, but for some patients the use of an ABO incompatible liver may be the best alternative.

Landsteiner's laws, first proposed in 1900, remain intact, if slightly shaken. ABO incompatibility is still a force to be heeded.

📜 SIMILAR VOLUMES

Immunization with a DNA vaccine candidat
Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination
✍ Marlen Castellanos; Zurina Cinza; Zaily Dorta; Gloria Veliz; Héctor Vega; Irma L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract ## Background In the present study, we evaluated the safety of CIGB‐230, a novel vaccine candidate based on the mixture of a plasmid for DNA immunization, expressing hepatitis C virus (HCV) structural antigens, with a recombinant HCV Core protein. ## Methods Fifteen HCV chronically‐i

Evolution of viral quasispecies in four
Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C
✍ Sabine Pingel; Sandra Weyer; Peter R. Galle; Hanns F. Löhr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Abstract In most patients, chronic hepatitis C virus (HCV) infection persists despite antiviral treatment with interferon‐alpha (IFN‐α) and ribavirin. The aim of the study was to determine whether HCV could evade cellular immune responses through mutations within T cell epitopes. Viral sequences